Chryssostomos Chatgilialoglu
Research Director
Catholic University of Lublin
Italy
Biography
Chryssostomos Chatgilialoglu is a Research Director at the Italian National Research Council (CNR) in Bologna, Italy. He is also co-founder and President of the spin-off company Lipinutragen. In 1983, he joined the Consiglio Nazionale delle Ricerche in Bologna (Italy) where he has been Research Director since 1991. In March 2014 he was appointed as the Director of the Institute of Nanoscience and Nanotechnology at the NCSR “Demokritos” in Athens (Greece) and from May 2015 he served as the vice-President of the NCSR “Demokritos”. He is the author or co-author of more than 250 publications in peer-reviewed journals, 34 book chapters, 6 patents, and 7 books, Author of the monograph Organosilanes in Radical Chemistry, Co-editor of the Encyclopedia of Radicals in Chemistry, Biology and Materials, Co-author of the Membrane Lipidomics for Personalized Health. The Chatgilialoglu’s research group is active in the field of free radical chemistry addressed to applications in life sciences. In the recent years, he developed biomimetic chemistry of radical stress and related biomarkers. The discovery of endogenous formation of trans-lipids attracted worldwide attention. He is responsible for introducing tris (trimethylsilyl) silane (TTMSS) as radical-based reducing agent and for this he was the winner of the Fluka Prize “Reagent of the Year 1990”. He had responsible functions within international projects, including Director of two NATO Advanced Study Institute on Sulfur-Centered Reactive Intermediates in Chemistry and Biology and on Chemical Synthesis: Gnosis to Prognosis; Chairman of the COST Action CM0603 on Free Radicals in Chemical Biology (2007–2011) and of the COST Action CM1201 on Biomimetic Radical Chemistry (2013–2016); Principal Investigator in various Framework Programs of the European Commission, comprising Horizon 2020; Supervisor of more than 15 PhD students and more than 30 Postdoctoral fellows.
Research Interest
Free radical reactivity applied to biosciences and biomarker discovery
